Osteopontin: A missing link between hedgehog signaling and fibrosis in nonalcoholic steatohepatitis

Hepatology

Volumn 53, Issue 2, 2011, Pages 382-384

  Machado, Mariana Verdelho ^a,b   Cortez Pinto, Helena ^a,b  

^a HOSPITAL DE SANTA MARIA   (Portugal)

^b INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; COLLAGEN; LEPTIN; METHIONINE; OSTEOPONTIN; PLATELET DERIVED GROWTH FACTOR; SONIC HEDGEHOG PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; DIET; DISEASE SEVERITY; EDITORIAL; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; LIVER CELL; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER REGENERATION; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; NUTRITIONAL DEFICIENCY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VIRUS HEPATITIS;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; FATTY LIVER; FIBROSIS; HEDGEHOG PROTEINS; HEPATOCYTES; HUMANS; LIVER; MICE; MICE, KNOCKOUT; OSTEOPONTIN; SIGNAL TRANSDUCTION;

EID: 79251475861     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.24118     Document Type: Editorial

References (20)

1. Volkmann X, Fischer U, Bahr MJ, Ott M, Lehner F, Macfarlane M, et al. Increased hepatotoxicity of tumor necrosis factor-related apoptosis-inducing ligand in diseased human liver. HEPATOLOGY 2007; 46: 1498-1508.
2. Yang SQ, Lin HZ, Mandal AK, Huang J, Diehl AM. Disrupted signaling and inhibited regeneration in obese mice with fatty livers: implications for NAFLD pathophysiology. HEPATOLOGY 2001; 34: 694-706.
3. Richardson MM, Jonsson JR, Powell EE, Brunt EM, Neuschwander-Tetri BA, Bhathal PS, et al. Progressive fibrosis in NASH: association with altered regeneration and a ductular reaction. Gastroenterology 2007; 133: 80-90.
4. Jung Y, Witek RP, Syn WK, Choi SS, Omenetti A, Premont R, et al. Signals from dying hepatocytes trigger growth of liver progenitors. Gut 2010; 59: 655-665.
5. Sicklick JK, Li YX, Melhem A, Schmelzer E, Zdanowicz M, Huang J, et al. Hedgehog signaling maintains resident hepatic progenitors throughout life. Am J Physiol Gastrointest Liver Physiol 2006; 290: G859-G870.
6. Das S, Harris LG, Metge BJ, Liu S, Riker AI, Samant RS, et al. The hedgehog pathway transcription factor GLI1 promotes malignant behavior of cancer cells by up-regulating osteopontin. J Biol Chem 2009; 284: 22888-22897.
7. Syn WK, Jung Y, Omenetti A, Abdelmalek M, Guy CD, Yang L, et al. Hedgehog-mediated epithelial-to-mesenchymal transition and fibrogenic repair in NAFLD. Gastroenterology 2009; 137: 1478-1488.
8. Sicklick JK, Choi SS, Bustamante M, McCall SJ, Perez EH, Huang J, et al. Evidence for epithelial-mesenchymal transitions in adult liver cells. Am J Physiol Gastrointest Liver Physiol 2006; 291: G575-G583.
9. Sicklick JK, Li YX, Choi SS, Qi Y, Chen W, Bustamante M, et al. Role for hedgehog signaling in hepatic stellate cell activation and viability. Lab Invest 2005; 85: 1368-1380.
10. Niswender KD, Gallis B, Blevins JE, Corson MA, Schwartz MW, Baskin DG. Immunocytochemical detection of phosphatidylinositol 3-kinase activation by insulin and leptin. J Histochem Cytochem 2003; 51: 275-283.
11. Gomez-Ambrosi J, Catalan V, Ramirez B, Rodriguez A, Colina I, Silva C, et al. Plasma osteopontin levels and expression in adipose tissue are increased in obesity. J Clin Endocrinol Metab 2007; 92: 3719-3727.
12. Bertola A, Deveaux V, Bonnafous S, Rousseau D, Anty R, Wakkach A, et al. Elevated expression of osteopontin may be related to adipose tissue macrophage accumulation and liver steatosis in morbid obesity. Diabetes 2009; 58: 125-133.
13. Lee SH, Seo GS, Park YN, Yoo TM, Sohn DH. Effects and regulation of osteopontin in rat hepatic stellate cells. Biochem Pharmacol 2004; 68: 2367-2378.
14. Zhao L, Li T, Wang Y, Pan Y, Ning H, Hui X, et al. Elevated plasma osteopontin level is predictive of cirrhosis in patients with hepatitis B infection. Int J Clin Pract 2008; 62: 1056-1062.
15. Liu P, Chen DF, Wang J, Ai ZL, Fan LL, Wang XM, et al. The expression and significance of osteopontin in the development of nonalcoholic fatty liver fibrosis in rats [in Chinese]. Zhonghua Gan Zang Bing Za Zhi 2008; 16: 831-834.
16. Sahai A, Malladi P, Melin-Aldana H, Green RM, Whitington PF. Upregulation of osteopontin expression is involved in the development of NASH in a dietary murine model. Am J Physiol Gastrointest Liver Physiol 2004; 287: G264-G273.
17. Arai M, Yokosuka O, Fukai K, Imazeki F, Chiba T, Sumi H, et al. Gene expression profiles in liver regeneration with oval cell induction. Biochem Biophys Res Commun 2004; 317: 370-376.
18. Chen RX, Xia YH, Cui JF, Xue TC, Ye SL. Osteopontin, a single marker for predicting the prognosis of patients with tumor-node-metastasis stage I hepatocellular carcinoma after surgical resection. J Gastroenterol Hepatol 2010; 25: 1435-1442.
19. Syn WK, Choi S, Liaskou E, Karaca G, Agboola K, Oo Y, et al. Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis. HEPATOLOGY 2011; 53: 106-115.
20. Hsieh A, Ellsworth R, Hsieh D. GLI1 regulates IRS1 expression to promote IGF dependent malignant behaviors in glioma stem cells. J Cell Physiol; doi:10.1002/jcp.22433.